Gastroesophageal Reflux Disease | NYU Langone Health
NYU Langone specialists care for patients with gastroesophageal reflux disease, or GERD, using advanced diagnostic technologies and treatments.
Gastrointestinal tract colonization and Staphylococcus aureus associated skin diseases
Our ultimate goal is to improve our understanding of the complex interplay of host, pathogen, and microbiome in Staphylococcus aureus-associated skin diseases. These diseases include both frank infection such as skin and soft tissue infections (SSTIs) and inflammatory diseases with a known high burden of Staphylococcus aureus colonization such as atopic dermatitis. We believe a deeper understanding of the perturbations of S. aureus colonization versus infection and contributions of human host genetics to these perturbations will provide strategies for improved prevention and treatment recommendations.S. aureus gastrointestinal (GI) colonization is an understudied aspect of cutaneous disease and may represent a reservoir for colonization and recurrent infection. The focus of the present proposal will be to determine the role of GI colonization in two syndromes: S. aureus skin abscesses (SSTI; an infection) and atopic dermatitis (AD; a S. aureus-associated skin disease). Furthermore, given that understanding commensal interactions requires consideration of not only environmental but host factors, we will test for an association between GI colonization, microbiota, and host susceptibility gene ATG16L1. ATG16L1 is implicated in inflammatory bowel disease, and our recent work demonstrates that it is associated with S. aureus GI tract colonization in mice. Toward these ends, we will obtain patient data and biobank stool, peripheral blood, and S. aureus from both sets of patients.
Gaucher Disease Outcome Survey (GOS)
The Gaucher Outcome Survey (GOS) is a long term observational survey. This survey aims to collect as much information as possible from as many Gaucher disease patients about the course of their disease, their medical management & the use of current or past medications or treatments, if any. Patient participation in GOS will be voluntary & GOS will be open to patients with Gaucher disease of any phenotype. Patients who are naïve to treatment, patients who are currently or have been previously treated with VPRIV, as well as patients who have been exposed to or are currently receiving other treatments for Gaucher disease may be included. This study is designed to gain a better understanding of the clinical course of the disease and its response to VPRIV therapy, thereby improving the clinical management of patients affected by Gaucher disease.
GBM AGILE TRIAL
Glioblastoma adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/III response adaptive randomization platform trial designed to evaluate multiple therapies in newly diagnosed (ND) and recurrent GBM. Its goals are to identify effective therapies for glioblastoma and match effective therapies with patient subtypes. Bayesian response adaptive randomization is used within subtypes of the disease to assign participants to Arms based on their performance. The primary endpoint is overall survival (OS).
Gender & Sexuality Service | NYU Langone Health
The Gender and Sexuality Service at the Child Study Center is part of Hassenfeld Children’s Hospital at NYU Langone.
General Compliance | NYU Langone Health
The Office of Internal Audit, Compliance, and Enterprise Risk Management supports NYU Langone Health’s commitment to a culture of compliance.
General Pediatric Services in Manhattan | NYU Langone Health
NYU Langone’s team of pediatric medicine experts offer several convenient care locations across Manhattan.
General Pediatric Services in Manhattan Doctors | NYU Langone Health
Find a doctor at the General Pediatric Services in Manhattan at NYU Langone.
General Surgery | NYU Langone Health
NYU Langone general surgeons perform surgical procedures for a wide range of conditions.
General Surgery Doctors | NYU Langone Health
Find a doctor at the General Surgery at NYU Langone.